Pathophysiology and Treatment of Spinal Cord Injury
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Neurology".
Deadline for manuscript submissions: closed (15 December 2023) | Viewed by 1650
Special Issue Editor
2. Department of Rehabilitation Medicine, Kyorin University School of Medicine, Mitaka City 181-8611, Japan
Interests: rehabilitation medicine (stroke, spinal cord injury and Hansen disease); neurorehabilitation; non-invasive transcranial brain stimulation; regenerative rehabilitation; orthotic treatment and robot rehabilitation; disaster rehabilitation; cancer rehabilitation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Background and history of the topic: Spinal cord injury (SCI) is a devastating event leading to paresis, sensory, autonomic, respiratory, and bowel disturbance that is permanent. There is no established treatment except for surgical procedures to restabilize the spine and decompress the spinal cord in the case of traumatic SCI. Whereas rehabilitative therapies are implemented after the acute treatments, the injured spinal cord exhibits only a small degree of plasticity and functional recovery.
Aim and scope of the Special Issue: The development of a new treatment is important, particularly to target its acute phase to influence the consequences thereafter. Researchers are discovering several points of action to suppress secondary damage in acute SCI, modify the microenvironment, and induce more plasticity toward functional recovery. This Special Issue focuses on newly developing fundamental treatments, including rehabilitative interventions and preventive measures.
Cutting-edge research: Regenerative treatments, Pharmacological treatment for the refractory state of SCI, Neurorehabilitation, etc.
What kind of papers we are soliciting: We are waiting for papers from the field of Neurology and Neurosurgery, Orthopaedic surgery, Urology, and Physical and Rehabilitation Medicine.
Dr. Syoichi Tashiro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stem cells
- scaffold
- neurotrophic factor
- anti-inflammation
- neurorehabilitation
- plasticity prevention
